NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘biolimus-eluting biodegradable-polymer-coated stent’

RSS

January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.

Categories: General
Tags: acute myocardial infarction, biolimus-eluting biodegradable-polymer-coated stent, cardiovascular risk, central arteriovenous anastomosis, dietary sodium, Elecsys Troponin T high-sensitive assay, high-sensitivity cardiac troponin, mortality, myocardial infarction, older patients, uncontrolled hypertension, women, zotarolimus-eluting durable-polymer-coated stent


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Complete Revascularization Guided by Functional Coronary Angiography in STEMI September 10, 2026
      Among patients with ST-segment elevation myocardial infarction and multivessel disease, physiology-guided angiography led to a lower risk of major cardiovascular events than conventional angiography-guided treatment.
    • Oveporexton for Narcolepsy Type 1 — Results from Two Phase 3 Trials September 9, 2026
      In two placebo-controlled trials, oveporexton improved wakefulness, reduced daytime sleepiness, and lowered the cataplexy rate among patients with narcolepsy type 1. Increased urinary frequency and transient insomnia were common.
    • Immediate Ambulatory Electrocardiographic Monitoring in Syncope August 31, 2026
      Among patients with syncope that remained unexplained after evaluation in the ED, immediate initiation of 14-day ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care.
    • Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism August 31, 2026
      Catheter-directed thrombolysis led to a lower risk of death, recurrent pulmonary embolism, or cardiorespiratory decompensation or collapse at 7 days than anticoagulation alone in intermediate-high–risk acute pulmonary embolism.
    • Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation August 30, 2026
      In patients with severe aortic stenosis and coronary artery disease, a strategy of transcatheter aortic-valve implantation before percutaneous coronary intervention was noninferior to PCI before TAVI for major clinical events at 1 year.
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |